Malathi Narasimhan

Malathi Narasimhan

Auto-generated profile, based on publicly available information

Malathi Narasimhan

Department of Oral and Maxillofacial Pathology, Sri Ramachandra Dental College, Faculty of Dental Sciences of Higher Education, Chennai, Tamil Nadu, India

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2016 in Journal of Investigative and Clinical Dentistry
Verified
Journal Article
Closed access
PDF file
PAPooja Adtani
Pooja Adtani
MNMalathi Narasimhan
Malathi Narasimhan
APAlan M. Punnoose
Alan M. Punnoose
HKHimavanth Reddy Kambalachenu
Himavanth Reddy Kambalachenu

27 June 2024 in Heliyon
Verified
Journal Article
Open access
KGK. Gayathri
K. Gayathri
AAAbhinand. P A
Abhinand. P A
VGVeeraraghavan Gayathri
Veeraraghavan Gayathri
VLV. Prasanna Lakshmi
V. Prasanna Lakshmi
DCD. Chamundeeswari
D. Chamundeeswari
NMN. Malathi
N. Malathi
Oral submucous fibrosis (OSMF) is a potentially malignant disorder with no permanent cure that affects the quality of life due to trismus. Computational pharmacology has accelerated the discovery of drug candidates for the treatment of incurable diseases. The present study aimed to screen the compounds of the miracle herb Centella asiatica with drug-likeness properties based on the absorption, distribution, metabolism, and excretion (ADME) properties. The pharmacological actions of these screened compounds against OSMF were identified by network pharmacology, gene ontology, pathway enrichment analysis, molecular docking, and simulation. Fifteen drug-like ligands were identified after virtual screening viz; asiatic acid, kaempferol, quercetin, luteolin, apigenin, bayogenin, gallic acid, isothankunic acid, madecassic acid, madasiatic acid, arjunolic acid, terminolic acid, catechin, epicatechin, and nobiletin. 850 potential targets were predicted for the ligands, which were analyzed against 354 proteins associated with OSMF. Compound pathway analysis and disease pathway analysis identified 53 common proteins. The GO enrichment analysis identified 472 biological process terms, 76 molecular function terms, and 44 cellular component terms. Pathway enrichment analysis predicted 142 KEGG pathways, 35 Biocarta pathways, and 236 Reactome pathways for the target proteins. The analysis revealed that the herb targets crucial events of fibrosis such as inflammation, oxidative stress, apoptosis, collagen deposition, and epithelial-mesenchymal transition. The common 53 proteins were used for protein-protein interaction (PPI) network analysis, which revealed 4 key proteins interacting with the phytocompounds viz; transforming growth factor-β1 (TGF-β1), mothers against decapentaplegic-3 (SMAD-3), mitogen-activated protein kinase-1 (MAPK-1) and proto-oncogene tyrosine-protein kinase (SRC). Molecular docking revealed that all ligands had a good binding affinity to the target proteins. Bayogenin had the highest binding affinity towards MAPK-1 (−9.7 kcal/mol), followed by isothankunic acid towards SRC protein (−9.3 kcal/mol). Madasiatic acid had the highest binding affinity to SMAD-3 (−7.6 kcal/mol) and TGF-β1 (−7.1 kcal/mol). Molecular dynamics simulation demonstrated stable ligand protein interactions of bayogenin and MAPK complex, isothankunic acid and SRC complex. This in silico study is the first to identify potential phytochemicals present in Centella asiatica and their target molecules, which might be responsible for reversing OSMF.

28 May 2024 in Oral Diseases
Verified
Journal Article
Closed access
NMN. Malathi
N. Malathi
SRSharada T. Rajan
Sharada T. Rajan
SWSaman Warnakulasuriya
Saman Warnakulasuriya

23 August 2020 in Cureus
Verified
Journal Article
Open access
PDF file
LSLokesh Sundaram
Lokesh Sundaram
VRVidhya Rathnavelu
Vidhya Rathnavelu
DVDivyambika Catakapatri Venugopal
Divyambika Catakapatri Venugopal
MNMalathi Narasimhan
Malathi Narasimhan
MSMythili Sabesan
Mythili Sabesan
SSSwarna Swetha
Swarna Swetha
Developmental anomalies are malformation which arises due to the disturbances during the development of the organs. Although there have been many studies that have described the prevalence of these anomalies in the oral cavity, none have specified the prevalence of clinically manifested anomalies and their distribution between gender. In this study, 500 patients aged 18 to 50 years were screened for clinically manifested developmental anomalies. These were then divided based on age, sex, and jaws, which were then analyzed using a chi-square test and tabulated. We detected anomalies in 12.2% of the study population. Supernumerary teeth were the most prevalent anomaly detected (4.25%). The frequency of developmental anomalies was higher in men (57.1%). Supernumerary teeth were the most widely recognized anomaly. Other anomalies identified were related to the shape and size of teeth. These anomalies can lead to severe orofacial problems. Therefore, proper care of these anomalies should be taken.

1 January 2025 in Journal of Oral and Maxillofacial Pathology
Verified
Journal Article
Open access
ATAyesha Tabassum
Ayesha Tabassum
MNMalathi Narasimhan
Malathi Narasimhan
THThamizhchelvan Hari
Thamizhchelvan Hari
SRSharada T Rajan
Sharada T Rajan
VSVijaya Nirmala Subramani
Vijaya Nirmala Subramani
Context: Sjogren’s syndrome (SjS) is an auto-immune disease with a chronic inflammation causing dysfunction of salivary and lacrimal glands, leading to dry eyes and dry mouth. Focal lymphocytic sialadenitis (FLS) and focus score (FS) are significant diagnostic criteria in SjS. Aims: To evaluate the FLS and FS and quantify FS in H&E sections of normal salivary gland, inflammatory conditions, and SjS group. Settings and Design: A total of 60 cases were included and divided equally among the groups – SjS, inflammatory conditions, and normal salivary gland. Methods and Material: The clinical symptoms, associated disease, and serological tests (ANA, SSA, SSB, RF) were obtained from the records of the patient. Immunohistochemistry (IHC) staining was done (anti-CD20 monoclonal antibody). All the H&E and IHC slides were assessed by independent observers and were taken up for evaluation. Results and Conclusions: In H&E sections, FLS and FS were found only in the SjS patients and not in normal and inflammatory conditions. CD20 expression was found to be positive in 55% of SjS cases but negative in the normal and inflammatory groups. FS had been upgraded in IHC CD20 staining. FLS and FSs should be strictly evaluated according to the criteria. It was found only in SjS patients and not in normal and inflammatory conditions. Furthermore, CD20 can be used as an adjunct marker to decide the theranostic and prognostic markers of SjS. The results showed that criteria for scoring FS should be strictly followed and CD20 IHC can be used as a prognostic marker.

26 August 2024 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
ARAmol A Raje
Amol A Raje
VKVishwottam Kandikere
Vishwottam Kandikere
SSShanmuganathan Seetharaman
Shanmuganathan Seetharaman
VGV Gayathri
V Gayathri
SJSrikanth Jeyabalan
Srikanth Jeyabalan
NMN. Malathi
N. Malathi
Diabetes mellitus (DM) has emerged as a leading global health problem. Diabetes is estimated to affect 425 million adults globally. Majority of diabetic patients take herbal medicines as supplement for the treatment of diabetes. The combined use of herbs and modern synthetic medicine has increased the possibility of pharmacokinetic (PK) and pharmacodynamic (PD) interactions. Momordica charantia (MC) commonly known as bitter melon/bitter gourd, is globally marketed for treatment of diabetes. Many diabetic patients consume MC extract along with antidiabetic drugs for better therapeutic effect with or without knowledge of health care provider.The current study evaluated PKPD herb-interaction of MC extract with glibenclamide (GLB) following oral administration either alone or in combination with MC extract for 28-consequative days. MC extract co-administratioin showed increased plasma exposure of GLB on Day-28 compared to glibenclamide alone treated groups with similar dosing regimen. Glibenclamide upon co-administration with MC extract showed improved pharmacodynamic parameters compared to glibenclamide alone treated groups suggesting synergistic or additive effect. Physician can reduce the glibenclamide dose in diabetic patients if they are taking MC as supplement.